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Abstract The tet(K) gene from Staphylococcus aureus was 
highly expressed in Escherichia coli by an alteration of its initia- 
tion codon from TTG to ATG and its ribosome-binding sequence 
from GAGG to GGAGG [Noguchi, N. et al. (1994) Biol. Pharm. 
Bull. 17, 352-355]. The inverted membrane vesicles prepared 
from the tet(K)-expressing cells showed respiration-dependent 
[3H]tetracycline transport comparable to the vesicles from the 
tet(B)-expressing cells. The affinity of Tet(K) vesicles to tetracy- 
cline was the same as that of Tet(B) vesicles, whereas the former 
Vm, x value was about 60% of the latter one. Contrary to Tet(B) 
vesicles, Tet(K) vesicles showed no significant minocycline up- 
take, which was consistent with the low minocycline resistance of 
the Tet(K)-producing cells. The tetracycline transport mediated 
by Tet(K) vesicles was coupled with proton transport and the 
translocation of 6°CoZ÷ ions as well as in Tet(B) vesicles. This 
observation indicates that the class K tetracycline resistance de- 
terminant from Gram-positive bacteria also encodes a metal- 
tetracycline/H ÷antiporter that is functionally similar to that en- 
coded by tet(B), although there is a considerable difference in the 
primary sequences and the putative topologies of these Tet pro- 
teins. 
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1. Introduction 
In Gram-negative bacteria, the mechanism for tetracycline 
resistance is mainly based on the active efflux of the drug out 
of the cells [2]. The active efflux is mediated by a metal-tetracy- 
cline/H* antiporter (Tet(B)), which exports a tetracycline-diva- 
lent cation complex by 1:1 antiport with a proton [3]. In order 
for tetracycline to be transported by the Tet(B) protein, the 
antibiotic must be bound to a divalent cation such as Co 2+, 
Mn 2+ or Mg 2+ [3]. These divalent cations are transported with 
the antibiotic by TetA [3]. The TetA protein in Gram-negative 
bacteria has 12 membrane-spanning se ments [4,5] and belongs 
to the major facilitator family [6]. 
On the other hand, in Gram-positive bacteria, there are sev- 
eral types of tetracycline resistance determinants [2]. Among 
them, the Tet(M) and Tet(O) proteins confer tetracycline r sis- 
tance through ribosomal protection [7,8]. There are two related 
classes of efflux proteins among Gram-positive bacteria which 
bear little homology to the efflux proteins of Gram-negative 
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bacteria: Tet(L) from Bacillus, Staphylococcus, and Streptococ- 
cus species [9,10] and Tet(K) from Staphylococcus aureus 
[11,12]. The amino acid sequence of Tet(L) shows 65% identity 
with Tet(K) [13]. Althoguh Tet(K) and Tet(L) have a detectable 
degree of similarity in the N-terminal sequences with that of the 
TetA proteins of Gram-negative bacteria [14], the C-termini 
have little homology with one another. In addition, the putative 
topologies of Tet(K) and Tet(L), based on their hydropathy 
profile, contain 14 membrane-spanning se ments [2] similar to 
QacA/B [15] and Mmr [16]. Thus, the latter is postulated to 
belong to a drug-exporter family different from that of Tet(B) 
of Gram-negative bacteria, Bmr [17], and Nora  [18], which 
have 12 membrane-spanning segments. Some of the cloned 
genes of Tet(L) have been expressed in E. coli, resulting in 
tetracycline resistance [19,20] due to active efftux [19]. In the 
case of Tet(K), two independent groups succeeded in express- 
ing the genes in E. coli in different ways [1,21]. Guay and 
Rothstein [21] expressed the tet(K) gene under the control of 
the lac repressor. On the other hand, Noguchi et al. [1] suc- 
ceeded in obtaining high level expression via its own promotor 
by some alterations in the initiation codon and the ribosome 
binding sequence. 
In this study, we report on the first direct detection of active 
tetracycline transport and tetracycline-dependent proton and 
divalent cation transport mediated by Tet(K) proteins by using 
inverted membrane vesicles prepared from E. coli cells express- 
ing the Tet(K) protein. The expression vector used in this study 
is pTZ1252, which was constructed by Npguchi etal. [1]. As a 
result, Tet(K) was proved to be a metal-tetracycline/H + an- 
tiporter similar to Tet(B) of Gram-negative bacteria. 
2. Materials and methods 
2.1. Materials 
[7-3H]Tetracycline and 6°COC12 were purchased from DuPont-New 
England Nuclear. [J4C]Minocycline was a gift from Lederle Japan Co., 
Saitama, Japan. All other chemicals were of reagent grade and from 
commercial sources. 
2.2. Bacterial strains and plasmids 
E. coli W3104 [22] was used as the host strain expressing the tet(K) 
gene and for preparation ofthe inverted membrane vesicles, pTZ 1252 
was constructed by insertion of a 2.3 kb HindlII fragment of pNS1, 
which carries the tet(K) gene of Staphylococcus aureus [12], into 
pUC119, in which the initiation codon and the ribosome binding se- 
quence (RBS) were changed from TTG to ATG and from GAGG to 
GGAGG, respectively, and the distance between the RBS and the 
initiation codon was altered from 4 to 11 bases [1]. 
2.3. Preparation of inverted membrane vesicles 
E. coli W3104/pTZ1252 ceils were grown in 1 liter of minimal me- 
dium supplemented with 0.2% glucose and 0.1% casamino acids. At the 
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middle of the logarithmic phase, tetA gene expression was induced for 
2 h by incubation with 1 gg/ml heat-inactivated chlortetracycline 
(HCTC). Inverted vesicles were prepared by disruption of the cells with 
a French press in 50 mM MOPS-KOH buffer (pH 6.6) containing 0.1 
M KCI and 10 mM EDTA. Then the vesicles were washed once with 
50 mM MOPS-KOH (pH 7.0) containing 0.1 M KCI. 
2.4. Transport assaying of inverted vesicles 
A mixture of 10 pl of the vesicle suspension (3.5 mg of protein/ml) 
and 0.5 pl of 250 mM NADH was preincubated at 30°C for 1 min. The 
uptake of tetracycline and minocycline was initiated by the addition of 
[3H]tetracycline and []4C]minocycline (final conc., 10 pM), respectively, 
in the presence of 40 gl of MOPS-KOH buffer (pH 7.0) containing 0.1 
M KC1 and COC12 (final conc., 50 pM), unless otherwise stated. After 
incubation at 30°C for the indicated periods, 2 ml of 5 mM MOPS- 
KOH (pH 7.0) containing 0.15 M LiCI was added, and then the mixture 
was immediately filtered through a Millipore filter (pore size, 0.45 pm) 
and washed twice, and then the radioactivity ofthe filter was measured. 
For the 6°Co2+ uptake assay, a mixture containing 10/tM unlabeled 
tetracycline and 50 pM 6°COC12 was used. The other procedures were 
the same as in assaying [3H]tetracycline uptake. 
2.5. Measurement of proton transport across the membrane by the 
fluoreseenee change of quinacrine 
Proton translocation across inverted vesicles was measured as the 
change in the fluorescence of quinacrine [23]. A suspension (25/ll) of 
inverted vesicles (2 mg protein/ml) was diluted with 1 ml of 50 mM 
MOPS-KOH (pH 7.0) containing 0.1 M KCI and 10 mM MgSO4. After 
the addition of 5 ,ul of a quinacrine solution (final, 160 pM) and 2.5 ,ul 
of 250 mM fl-NADH (final, 625 gM), the emission (500 nm)/excitation 
(440 nm) ratio was monitored. Then, 10 pl of 2 mM tetracycline solu- 
tion (final, 20pM) was added at the indicated period. Finally 2.5/A of 
10 mM CCCP (final, 25 ~M) was added to destroy ApH. 
3. Results 
3.1. Tetracycline transport activity of the Tet(K) protein in 
inverted membrane vesicles prepared from E. coli cells 
Inverted membrane vesicles were prepared from E. coli 
W3104/pTZ 1252 cells in which the expression of Tet(K) was at 
first induced by HCTC. As shown in Fig. 1A, the initial rate 
of [3H]tetracycline uptake by inverted vesicles of the induced 
Table 1 
Kinetic constants for tetracycline uptake by inverted membrane v sicles 
prepared from E. coli W3104 cells carrying pTZ1252 and pLGT2, 
which encode Tet(K) and Tet(B) proteins, respectively 
Plasmid Km Vm,x 
(pM) (nmol/mg protein/30 s) 
pTZ1252 35.6 (+ 4.0) 9.4 (_+ 0.9) 
pLGT2 36.2 (+ 11.6) 14.9 (_+ 4.0) 
These constants were calculated by non-linear regression. The values 
in parentheses indicate a standard error. 
cells was 1.26 nmol/mg protein/30 s. This was the same level as 
that of the vesicles prepared from Tet(B)-induced E. coli 
W3104/pLGT2 cells (1.37 nmol/mg prtoein/30 s). Thus, it is 
clear that Tet(K) can mediate tetracycline transport in E. coli 
cells. The vesicles prepared from the uninduced cells showed 
almost the same level of tetracycline transport activity as that 
of induced cells (Fig. 1B). The expression of Tet(K) in Staphy- 
lococcus aureus is inducible, however, the mechanism of induc- 
tion is different from Tet(B) [12]. The tet(K) operon carries no 
gene for the reppressor protein. Instead, it contains a short 
ORF-D encoding a leader peptide, which acts as a control 
region in the upstream region of the Tet(K) structural gene [12]. 
In the plasmid, pTZI252, the control region might not work 
due to the alteration in the ribosome binding sequence (RBS) 
and the distance from the RBS to the initiation codon [1]. When 
tet(K) gene expression was induced by 1 pg/ml tetracycline, the 
uptake by the vesicles was almost the same as in Fig. 1A and 
B (data not shown). 
Table 1 shows the kinetic constants of tetracycline uptake by 
inverted vesicles prepared from the E. coli W3104 cells carrying 
pTZ1252 or pLGT2. It is noteworthy that the K m values of the 
two vesicles were almost he same in each other, indicating the 
similarity of the substrate affinity of Tet(K) and Tet(B). On the 
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Fig. 1. Tetracycline (TC) uptake by inverted membrane vesicles prepared from E. coli W3104/pTZ1252 cells, which carry tet(K) gene. In panel (A), 
the expression of tet(K) gene was induced for 2 h by 1 ¢tg/ml heat-inactivated chlortetracycline (HCTC) at the mid-log phase. In panel (B), cells were 
grown without induction. The uptake assay was carried out in the presence of 10 gM [3H]tetracycline and 50 gM COC12. Closed symbols indicate 
the uptake when the vesicles were energized by 2.5 mM NADH. Open symbols indicate the uptake without energization f the vesicles. 
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Fig. 2. Minocycline (MINO) uptake by inverted membrane vesicles prepared from E. coli W31041pTZ1252 cells, which carry tet(K) gene (A), and 
E. eoli W3104/pLGT2 cells, which carry tet(B) gene (B). The uptake assay was carried out in the presence of 10/IM [t4C]minocycline and 50/IM 
CoCl2. Closed and open circles represent the uptake in the presence and absence of 2.5 mM NADH, respectively. 
other hand, the Vma x value of the Tet(K) vesicles was about 60% 
of that of the Tet(B) vesicles. 
3.2. Minocycline transport mediated by the vesicles containing 
Tet(K) or Tet(B) 
Minocycline is a hydrophobic derivative of tetracycline [24], 
which is more efficient antibiotic against etracycline resistant 
organisms than tetracycline and the other derivatives. The 
tet(B) gene confers moderate resistance to minocycline, 
whereas tet(K) gene confers only very low resistance [21]. 
Minocycline uptake by inverted membrane vesicles was meas- 
ured under the same condition as that of tetracycline uptake 
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Fig. 3. The uptake of Co 2÷ by inverted vesicles prepared from E. eoli 
W3104/pTZ 1252 cells. The uptake was measured in the presence of 10 
,uM tetracycline, 50/.tM 6°COC12, and 2.5 mM NADH (closed circles). 
Open circles indicate the uptake without energization by NADH. 
Closed squares indicate the uptake in the absence of tetracycline. 
except for using 10 jIM [14C]minocycline. The active minocy- 
cline uptake, which is represented by the difference between the 
uptake in the presence and absence of NADH, by Tet(B) vesi- 
cles was 0.78 nmol/mg protein/30 s (Fig. 2B), whereas the active 
uptake by Tet(K) vesicles was not significant (Fig. 2A). The 
high background uptake of minocycline by both vesicles was 
due to the simple diffusion via the lipid bilayer region. 
3.3. Tetracycline-dependent 6°Co 2÷ transport mediated by 
Tet(K) 
As shown in Fig. 3, inverted membrane vesicles containing 
Tet(K) showed respiration-driven tetracycline-dependent 
6°Co2+ uptake. In the absence of tetracycline or NADH, the 
uptake was only at the background level. The initial rate of 
6°Co2+ was  about 2.9 nmol/mg protein/30 s, which was compa- 
rable to that mediated by Tet(B) [3]. The net rate of 6°Co2+ 
uptake was about twice the rate of [3H]tetracycline uptake 
under the same condition, probably due to leakage of free 
tetracycline through the lipid bilayer region of the membrane 
[251. 
3.4. Tetracycline-dependent pro on transport in inverted 
membrane vesicles containing Tet(K) 
When NADH was added to the suspension of the inverted 
membrane vesicles mixed with quinacrine, the fluorescence of 
quinacrine was quenched epending upon the pumping of pro- 
tons into the vesicles via the respiratory chain (Fig. 4). The 
addition of tetracycline to the suspension of vesicles prepared 
from the Tet(K)-producing cells (Fig. 4A) and Tet(B)-produc- 
ing cells (Fig. 4B) caused a restoration of the flourescence, 
indicating that proton efflux from the vesicles is coupled with 
Tet(K) or Tet(B) mediated tetracycline uptake. In contrast, 
when tetracycline was added to the vesicles from the host cells 
carrying no plasmid, no fluorescence hange was observed (Fig. 
4C), clearly indicating that the tetracycline-dependent fluores- 
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Fig. 4. Proton translocation across inverted membrane v sicles containing Tet(K) (A), Tet(B) (B), and no Tet protein (C). The vesicles were prepared 
from E. coli W3104 cells carrying pTZ1252, pLGT2 and no plasmid, respectively. The fluorescence of quinacrine (160/tM) was monitored. At 
indicated periods, 625/zM NADH, 20/IM tetracycline, and 25/IM CCCP were added in this order. 
cence change was mediated by Tet(K) and Tet(B). The degree 
of tetracycline-dependent fluorescence change in the Tet(K) 
vesicles was comparable to that in the Tet(B) vesicles. 
4. Discussion 
In this study, we first proved that the tetracycline fflux 
protein of Gram-positive bacteria is an antiporter of a tetracy- 
cline-divalent cation complex with proton similar to the TetA 
of Gram-negative bacteria. The sequence homology of Tet(K) 
and Tet(L) with the efflux proteins of Gram-negative bacteria 
was less than that with QacA/B and Mmr [2], whereas the latter 
two were transporters of completely different substrates. Like- 
wise, the homology between Tet(B), Bmr, and NorA is higher 
than that between Tet(B) and Tet(K) [2], whereas Bmr and 
NorA are multidrug exporters [26]. Therefore, according to the 
amino acid sequence, Tet(K) and Tet(L) belong to a different 
family of drug exporters to the TetA of Gram-negative bacteria 
in spite of the similarity of their substrate specificity. However, 
the tetracycline export mechanism ofTet(K) is the same as that 
of Tet(B) as shown in this study. 
It should be noted that Tet(K) showed tetracycline transport 
activity comparable to Tet(B) in E. coli cells as shown in this 
study. Tet(B) is known to be the most efficient exporter of 
teracycline among the drug exporters of Gram-negative bacte- 
ria [27]. The detectable similarity in the amino acid sequence 
of Tet(K) and Tet(B) is only detected in their N-terminal se- 
quence [2]. These observation may suggest that the N-terminal 
region contributes not only to substrate recognition but also to 
substrate/proton coupling. 
The Tet(B) protein contains four essential Asp residues, 
Asp ~5, Asp 66, Asp s4, and Asp 285. Three of them are located in 
the N-terminal region. Among them, only Asp 66 is located in 
the hydrophilic loop region [28], whereas the other three aspar- 
tic acid residues are located in the hydrophobic transmembrane 
region [29]. Tet(K) also contains Asp TM corresponding to Asp 66 
of Tet(B) in the widely-conserved sequence motif. However, 
Tet(K) has no Asp residue in the putative transmembrane re- 
gion. Instead of Asp residues, there are two Glu residues, Glu ~52 
and Glu 397, in the transmembrane region of Tet(K). The posi- 
tions of these residues are different from the Asp residues of 
Tet(B). It is surprising that such different proteins can mediate 
the same mechanism of metal-tetracycline/H + antiport. The 
comparative studies of the site-directed mutants of Tet(K) and 
Tet(B) are now in progress. 
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